Neurolixis Announces Scientific Publication Demonstrating Rapid and Long-Lasting Antidepressant Activity of NLX-101 in a Robust Rodent Model
DANA POINT, Calif. - -- Neurolixis, Inc. announced the publication of scientific data demonstrating rapid and long-lasting antidepressant activity of the Company's 'biased agonist' drug candidate, NLX-101 in a robust rodent model of depression. The...
Hamlin Emory, M.D. a recognized pioneer and specialist in applying EEG & QEEG data to the treatment of each patient announces the addition of Mark L. Shatsky D.O. to the Emory Neurophysiologic Institute (EM-NPI). Dr. Shatsky is a board certified family ph